Company profile for Arrow Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Following the Strides purchase of the Aspen Australia Generics business finalised on September 1, 2015, Arrow pharmaceuticals begins operating in the Australian market for the second time. Although the business re-enters the market under new owners and our industry has changed significantly in the fifteen years, the passion and determination for change remains in the DNA of the name and the business. Backed by the global stre...
Following the Strides purchase of the Aspen Australia Generics business finalised on September 1, 2015, Arrow pharmaceuticals begins operating in the Australian market for the second time. Although the business re-enters the market under new owners and our industry has changed significantly in the fifteen years, the passion and determination for change remains in the DNA of the name and the business. Backed by the global strength of Strides, and working off the strong foundation already built in the business that has been purchased.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
15-17 Chapel Street Cremorne Victoria 3121
Telephone
Telephone
+61 13009 27769
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201452

FDA
06 Mar 2023

https://www.prnewswire.com/news-releases/blueprint-medicines-reports-arrow-trial-data-at-esmo-virtual-congress-2020-demonstrating-durable-clinical-benefits-of-gavreto-pralsetinib-in-patients-with-advanced-ret-mutant-medullary-thyroid-cancer-301134311.html

PRNEWSWIRE
20 Sep 2020

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-29-2018-1535509071.pdf

FDA
29 Aug 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-1-2018-1533104328.pdf

FDA
01 Aug 2018

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/arrow-pharma-acquires-australian-operations-of-amneal-pharma/articleshow/60311034.cms

ECONOMIC TIMES
01 Sep 2017

http://www.smh.com.au/national/health/second-valium-manufacturer--arrow-recalls-medication-after-fears-of-tampering-at-sydney-factory-20170609-gwoklh.html

Kate Aubusson SMH
09 Jun 2017

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty